FindTrial
Sign In

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00532506
Enrollment
Unknown
Registered
2007-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2008-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Brief summary

The purpose of this study is to evaluate the clinical efficacy and safety of SK-0403 in patients with Type2 Diabetes Mellitus

Interventions

DRUGSK-0403

Sponsors

Sanwa Kagaku Kenkyusho Co., Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 74 Years
Healthy volunteers
No

Inclusion criteria

* Treatment-naive subjects diagnosed with type 2 diabetes mellitus * Stable diet program for at least 8 weeks * Criteria for HbA1c are met

Exclusion criteria

* Type 1 diabetes * Patients treated with other antidiabetic drugs or Insulin

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026